been reported to exhibit somatic MEN1 gene mutation and loss of heterozygosity (LOH) of the MEN1 locus, respectively [3] . These findings suggest that the complete loss of menin is an important step in the development of not only hereditary but also subsets of sporadic endocrine tumors.
Menin is ubiquitously expressed and mainly targeted to the nucleus [4, 5] . Although its molecular function is not fully understood, menin has been shown to modify chromatin structure and thereby regulate the transcription of many target genes including cyclindependent kinase inhibitor (CDKI) genes p18 Ink4c and p27 Kip1 [2, 6] . Menin-induced expression of these CDKI genes seems to be relevant to tumor suppressor function of menin because inactivating germline mutations of the CDKI genes p15 Ink4b , p18 Ink4c , p21 Cip1 and p27 Kip1 are known to cause MEN1-like syndromes [7, 8] .
pRc/CMV expression vector (Invitrogen, USA) after blunting each end as described previously [5] . The plasmid was transfected with FuGENE6 transfection reagent (Roche, USA) and were harvested 48 h after transfection.
Menin siRNA or scrambled negative control siRNA (menin siRNA (h), sc-35922 and control siRNA-A, sc-37007, Santa Cruz Biotechnology, USA) were transfected by the procedures recommended by the supplier into culture cells that were seeded at 5 × 10 5 cells per 35 mm plate the day before transfection. After transfection, cells were cultured in normal growth media for 48 h before collection.
Real-time RT-PCR
Total RNA was extracted from cells with the RNeasy Mini Kit (Qiagen, USA). Specific mRNA was quantified by real-time PCR using a Fluorescent Quantitative Detection system (BioFlux, USA) with QuantiTect SYBR Green RT-PCR assay kits (Qiagen). The mRNA value for each gene was normalized relative to the human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels in RNA samples. The following PCR primers were used for each mRNA. Menin: sense, TTAGGGAACCTGGCAGATCTAGAG; antisense, GTAGCCAGCCAGGTACATGTAGG; GAPDH: sense, TGCACCACCAACTGCTTAGC; antisense, AGTGATGGCATGGACTGTGG. Statistical comparison of mean values was performed by the Student's ttest. Differences with a p value of less than 0.05 were considered statistically significant.
Western blotting
Whole cell lysates were prepared as described previously [12] . Protein samples separated by electrophoresis and blotted onto nitrocellulose membrane (Invitrogen) were subjected to antibody binding as described previously [13] . The following antibodies were used: goat polyclonal anti-menin (C-19, sc-8200), rabbit polyclonal anti-p27
Kip1 (C-19, sc-528), rabbit polyclonal ant-p15
Ink4b (K-18, sc-613), anti-mouse IgG-HRP and anti-goat IgG-HRP antibodies were purchased from Santa Cruz Biotechnology. Mouse monoclonal anti-actin antibody (clone C4, #MAB1501) was obtained from Millipore (USA). Mouse monoclonal anti-caspase 8 antibody (12F5, ALX-804-242) was provided by ENZO Life Sciences (USA). The blots were visualized by On the other hand, previous studies have shown that menin plays a crucial role in promoting apoptosis, which depends on proapoptotic proteins of Bax and Bak [9] . Menin has also been demonstrated to induce the expression of caspase 8 mRNA and protein by enhancing histone acetylation at the 5'-untranslated region of the caspase 8 gene in murine embryonic fibroblasts [10] . Moreover, caspase 8 expression has been shown to decline in pancreatic islets and insulinomas in heterozygous MEN1 gene knockout mice, the murine model of the human MEN1 syndrome [10] . These findings suggest that menin-dependent caspase 8 expression plays a role in tumor suppression. Because caspase 8 is a key protein in the deathreceptor pathways, tumors lacking caspase 8 may be resistant to apoptosis-inducing therapy [11] .
Although the endocrine tumors in the murine MEN1 model showed decreased caspase 8 expression, it remains uncertain whether the human endocrine tumors lacking menin exhibit similarly lowered caspase 8 levels. To clarify the relationships between caspase 8 and menin expression levels in human tumors, we have studied caspase 8 proteins in human culture cells and in parathyroid tumors associated with MEN1 and non-hereditary parathyroid tumors. We report here that caspase 8 expression was downregulated by menin knockdown in human culture cells, but human parathyroid tumors had variable amounts of caspase 8 proteins irrespective of menin expression levels.
Materials and Methods
Cell culture and transfection of expression plasmid and siRNA WI38-VA13 and GM0639 cells, the human fibroblasts derived from normal persons and immortalized with SV40, and HEK293T cells, the transformed human embryonic kidney cells, were maintained in DMEM supplemented with 10 % fetal bovine serum and antibiotics as described previously [12] . GM0639 cells were treated with 50 µM etoposide for 48 h to be served as a control for procaspase and cleaved caspase proteins in Western blotting.
The menin-expressing plasmid was constructed by inserting the protein-coding region of the menin cDNA plasmid (p1533, kindly donated by Dr. M. Ohki and Dr. F. Hosoda, National Cancer Center Research Institute, Japan) into the unique HindIII site of the enhanced chemiluminescence method (RPN2135, GE Healthcare, UK) and imaging system LAS3000 (Fujifilm, Japan). Images were analyzed with the ImageJ software.
Blood and tumor specimens
Patients with primary hyperparathyroidism were diagnosed as having non-hereditary, sporadic parathyroid tumor or hereditary tumors in the local hospitals (Table 1 ). The diagnosis of MEN1 was confirmed by DNA analysis for heterozygous germline MEN1 gene mutation. Seven parathyroid tumors surgically removed from 6 patients affected with MEN1, including 2 tumors arising from different parathyroid glands of a patient (case 4), and 6 parathyroid tumors from 6 patients with nonhereditary, sporadic parathyroid tumor were examined. The tumors were pathologically diagnosed as benign multiple adenomas or hyperplasia in the MEN1 cases and as benign adenoma in sporadic cases.
Peripheral blood was collected from all MEN1 patients except for one patient (case 3) and used for the confirmation of germline mutation and LOH analysis. Prior informed consent was obtained for germline mutation analysis of blood DNA. Some tumors were analyzed after unlinkable anonymization without informed consent for gene analysis. This study was approved by the ethics committee for gene analysis research of the National Cancer Center and Kobe University Graduate School of Medicine.
Analysis of MEN1 gene mutation and loss of heterozygosity
The MEN1 gene sequence in the blood and tissue DNA was analyzed for mutations by the direct nucleotide sequencing of PCR-amplified exons as described previously [14] . In a MEN1 patient whose germline mutation was not detectable by the conventional sequencing method (case 6), a gross deletion involving exon 8 was detected by PCR-based DNA walking (manuscript in preparation). Loss of heterozygosity in the chromosome 11q13 region was examined at the polymorphic DNA marker sites, PYGM, D11S4940 and D11S4946, as described previously [15] . In addition, reduction of the wild type sequence in the tumor DNA at the site of heterozygous germline mutation was also considered as LOH.
Results

Effects of knockdown and overexpression of menin on caspase 8 expression in human cell lines
Because menin knockdown has been shown to suppress caspase 8 expression in murine cells, we examined the effect of menin on caspase 8 expression in human cell lines derived from normal fibroblasts. Introduction of menin siRNA into WI38-VA13 and GM0639 cells reduced the menin mRNA and protein levels (Fig. 1) . The caspase 8 expression levels were also decreased in the both cell lines by the transfection of menin siRNA (Fig. 1) . On the other hand, menin overexperssion in WI38-VA13, GM0639 and HEK293T cells by the transfection of menin expression plasmid did not change procaspase 8 protein levels (Fig. 2) . These findings suggest that menin is crucial for caspase 8 expression and that these cells contain sufficient amount of endogenous menin which allow full expression of procaspase 8 protein.
MEN1 gene status in parathyroid tumors
In order to examine the effect of menin in human tumors, parathyroid tumors surgically removed from patients affected with MEN1 were used as tumors lacking menin (Table 1) . The blood DNA analysis confirmed the presence of germline mutations in all the MEN1 patients except for case 3 whose blood was not available for this study. Comparison of blood and tumor DNA sequences and polymorphic markers revealed LOH in all tumors from the MEN1 patients except for case 3. In the tumor DNA of case 3, which showed the typical manifestations of MEN1 with positive family history of endocrine tumors, the mutated sequence TAG at codon 358 was predominant and the wild type sequence GAG was almost absent (data not shown). These findings suggest that the nonsense mutation E358X (GAG>TAG) is the germline mutation of this family and that the wild-type allele was lost in the tumor cells although it is theoretically possible that a large genomic deletion is the germline mutation of this family and that E358X is a somatic mutation. Altogether, the absence of the normal MEN1 gene was confirmed in the neoplastic cells of all the tumors from the MEN1 patients examined.
Sporadic parathyroid tumors were used as counterpart specimens, which had normal MEN1 alleles (Table 1) . Because MEN1 gene inactivation is also involved in a subset of sporadic parathyroid tumors, we selected only the tumors that had no detectable MEN1 gene mutation. In order to minimize the possibility of including tumors having MEN1 gene mutation that escape detection in our mutation analysis, we further selected sporadic tumors that exhibited at least one heterozygous normal polymorphic sequences at codon 418 (GAC/GAT) or codon 541 (GCA/ACA) [1] , which are usually hemizygous in tumors involving MEN1 gene inactivation.
Menin, caspase 8 and CDKI protein levels in parathyroid tumors
Western blotting analyses confirmed that menin protein levels were markedly reduced in parathyroid tumors from MEN1 patients compared with sporadic tumors although some variability was observed (Fig. 3) . The faint band of menin with the authentic size detected in the MEN1 tumors should represent menin protein in the non-neoplastic cells in the tumor tissue.
Procaspase 8 protein levels were much more variable among tumors, and there was no constant correlation between menin and procaspase 8 levels (Fig. 3) . The cleaved caspase 8 also showed variable expression levels. Even the individual tumors from the same patient (4a and 4b) showed different caspase 8 expression levels. These findings suggest that, while reduction of menin causes decreased procaspase 8 expression in human culture cells in vitro, the procaspase 8 and cleaved caspase 8 protein levels in human parathyroid tumors are not simply determined by menin Fig. 3 Menin, caspase 8, p27
Kip1 and p15 Ink4b expression detected by Western blotting in human parathyroid tumors. The samples in lanes 1 -6 and lanes 7 -12 are tumors from the MEN1 patients and sporadic tumors, respectively, and correspond to those summarized in Table 1 . GM0639 cells transfected with menin-expressing plasmid (+) along with non-transfected cells (-) were used as the size marker for normal menin. GM0639 cells treated with etoposide (Et) were used as the size marker for procaspase 8 (Pro-CP8) and cleaved caspase 8 (Cleaved-CP8). Actin was served as a loading control. [11]. Interferon gamma and retinoic acids have been reported to induce caspase 8 expression in some tumor cell lines [11] . Such extracellular signals may be involved in the regulation of parathyroid cell growth and apoptosis under the physiological condition, and leading to variable caspase 8 expression levels. The distinct caspase 8 expression patterns in the individual tumors form the same patient (4a and 4b) (Fig. 3 ) may reflect the difference of tumor microenvironment. Alternatively, genetic or epigenetic change of the caspase 8 gene might explain the variable expression. Caspase 8 gene has been shown to be deleted in neuroblastoma [16] . In addition, caspase 8 gene is frequently inactivated by silencing through DNA methylation in various tumors including neuroblastoma and lung carcinoma [11, 16] . The human parathyroid tumors are usually diagnosed and removed after long periods of tumor growth, while tumors developed in the knockout mice were examined earlier, usually less than a year after birth. Therefore, alterations of the caspase 8 gene per se might be more prevalent in human tumors than in the murine models. Our present study revealed complex caspase 8 expression patterns in human tumors that may not simply reflect the phenomenon observed under experimental conditions. In contrast to caspase 8 expression, p27 Kip1 , which was also demonstrated to be up-regulated by menin at the transcriptional level [6] , was more abundant in sporadic parathyroid tumors than in tumors from MEN1 patients. These findings are consistent with those reported previously [6] and support the important role of menin in regulating p27
Kip1 expression. Interestingly, we found no correlation of p15
Ink4b protein levels with MEN1 gene mutation status. The expression of p15
Ink4b has also been shown to be upregulated by menin [17] . However, the previous chromatin immunoprecipitation studies suggested that the enhancing effect of menin on p15
Ink4b gene expression may be indirect in contrast to that on p27 Kip1 gene, which is likely to be regulated through direct binding of menin-containing protein complex to the gene promoter region [17] . Our findings are in line with the previous report that p15
Ink4b mRNA levels were not correlated with MEN1 gene mutation status in human pancreatic endocrine tumors [18] . The p15
Ink4b gene promoter hypermethylation has also been demonstrated to be associated with gene silencing in some endocrine tumors [18] . expression levels but also regulated by other unknown mechanisms.
The expression levels of CDKIs p27 Kip1 and p15
Ink4b
were also examined (Fig. 3) . The amount of p27 Kip1 was reduced in all tumors from MEN1 patients except for one case (case 6) while only one case (case 7) of sporadic tumor showed reduced p27 Kip1 expression. Thus, the expression of p27
Kip1 was roughly correlated with menin expression levels. On the other hand, the expression of p15
Ink4b was not related to MEN1 gene mutation status. We also attempted to compare p18 Ink4c and p21
Cip1 expression levels in these tumors but failed to detect reproducible specific signals.
Discussion
Menin has been reported to up-regulate the expression of caspase 8 by activating gene transcription and enhance apoptosis in murine fibroblasts [9] . It has also been demonstrated that caspase 8 expression is reduced in the pancreatic islet tumors occurring in the heterozygous MEN1 gene knockout mice, the murine model of the human MEN1 syndrome [10] . However, caspase 8 expression has not been examined in the human endocrine tumors, in which the MEN1 gene is completely inactivated. We compared caspase 8 and menin expression levels in human parathyroid tumors from patients affected with MEN1 and non-hereditary, sporadic hyperparathyroidism, and found that caspase 8 protein levels were not correlated with menin protein levels in these tumors.
The discrepancy is not probably due to the species difference because our in vitro experiments employing human cells reproduced menin-dependent caspase 8 expression similar to the previous findings with the murine cells. It is also unlikely that an aberrant caspase 8 gene expression is simply associated with oncogenic transformation of endocrine cells because caspase 8 levels have been shown to decline in the murine pancreatic islet tumors lacking menin [10] , although the difference of the cell lineage might explain the discrepancy. Examination of human pancreatic islet tumors with verified MEN1 gene mutations may clarify this possibility.
Another possibility of the apparent discrepancy is the difference of the tumor environments. It is suggested that the basal caspase 8 expression levels are controlled through signals culminating in the activation of SP1 and ETS-like transcription factors
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In conclusion, we observed coordinated expression of p27 Kip1 and menin in human parathyroid tumors but variable expression levels of caspase 8 and p15
Ink4b irrespectively of MEN1 gene mutation status. Because caspase 8 is a crucial component in the apoptosis pathway, low caspase 8 expression is implicated in the resistance against apoptosis-inducing therapy of tumors [11] . Our findings suggest that the human endocrine tumors lacking menin may not always exhibit lower caspase 8 protein expression and hence may not be resistant to such therapy.
